ADD CONDITION

items per page

Physicianscare Sinus

Last content change checked dailysee data sync status

Active ingredient
Phenylephrine Hydrochloride 10 mg
Other brand names
Drug class
alpha-1 Adrenergic Agonist
Dosage form
Tablet, Film Coated
Route
Oral
Prescription status
OTC (over the counter)
Marketed in the U.S.
Since 2012
Label revision date
September 8, 2025
Active ingredient
Phenylephrine Hydrochloride 10 mg
Other brand names
Drug class
alpha-1 Adrenergic Agonist
Dosage form
Tablet, Film Coated
Route
Oral
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Marketed in the U.S.
Since 2012
Label revision date
September 8, 2025
Manufacturer
Acme United Corporation
Registration number
M012
NDC root
0924-0133

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

Physicians Care® Non-Drowsy Sinus Decongestant is a medication designed to help clear sinus pressure and congestion. It comes in coated tablet form and is packaged in tamper-evident packets, with each packet containing one tablet. This decongestant temporarily relieves nasal congestion caused by the common cold, hay fever, or other upper respiratory allergies, and it also helps alleviate sinus congestion and pressure while promoting nasal and sinus drainage.

The active ingredient in this product is Phenylephrine HCl (a type of medication that helps reduce swelling in the nasal passages), which works to provide relief from discomfort associated with sinus issues.

Uses

If you're dealing with nasal congestion from a common cold, hay fever, or other upper respiratory allergies, this medication can help provide temporary relief. It also works to ease sinus congestion and pressure, making it easier for you to breathe. Additionally, it promotes drainage in your nasal passages and sinuses, which can further alleviate discomfort.

Dosage and Administration

If you are an adult or a child aged 12 years and older, you should take 1 tablet every 4 hours as needed. However, make sure not to exceed 6 doses in a 24-hour period to avoid any potential risks.

For children under 12 years of age, it is important to note that this medication should not be given to them. Always follow these guidelines to ensure safe and effective use of the medication.

What to Avoid

You should avoid using this product if you are currently taking a prescription monoamine oxidase inhibitor (MAOI), which is a type of medication used for depression, psychiatric conditions, or Parkinson's disease. Additionally, do not use this product for at least two weeks after stopping an MAOI. If you're unsure whether your prescription includes an MAOI, please consult your doctor or pharmacist.

While using this product, it’s important not to exceed the recommended dosage. Doing so can lead to serious health risks, including potential misuse or dependence (a condition where your body becomes reliant on a substance). Always prioritize your safety and well-being by following these guidelines.

Side Effects

If you experience nervousness, dizziness, or sleeplessness while using this medication, it's important to stop use and consult your doctor. Additionally, if your symptoms do not improve within 7 days or are accompanied by a fever, you should also seek medical advice.

Before using this medication, talk to your doctor if you have any of the following conditions: heart disease, high blood pressure, thyroid disease, diabetes, or difficulty urinating due to an enlarged prostate gland. There are no specific side effects or additional adverse reactions listed for this medication.

Warnings and Precautions

Before using this medication, it's important to consult your doctor if you have any of the following conditions: heart disease, high blood pressure, thyroid disease, diabetes, or difficulty urinating due to an enlarged prostate gland. These conditions may affect how the medication works for you.

If you suspect an overdose, seek emergency medical help or contact a Poison Control Center immediately. Additionally, you should stop taking the medication and call your doctor if you experience nervousness, dizziness, or sleeplessness, or if your symptoms do not improve within 7 days or are accompanied by a fever. Your health and safety are the top priority, so don’t hesitate to reach out for help if needed.

Overdose

It appears that there is no specific information available regarding overdosage for this medication. However, it's always important to be aware of the signs of an overdose, which can include symptoms like extreme drowsiness, confusion, or difficulty breathing. If you suspect that you or someone else may have taken too much of a medication, it’s crucial to seek immediate medical help.

In case of an overdose, contact your local emergency services or go to the nearest hospital. Having the medication packaging or information on hand can help medical professionals provide the best care. Always remember to use medications as directed by your healthcare provider to minimize the risk of an overdose.

Pregnancy Use

If you are pregnant or breastfeeding, it’s important to consult with a healthcare professional before using this medication. They can provide guidance on whether it’s safe for you and your baby. Always prioritize your health and the health of your child by seeking expert advice.

Lactation Use

If you are pregnant or breastfeeding, it’s important to consult with a healthcare professional before using any medication. This ensures that you understand any potential risks and can make informed decisions about your health and the health of your baby. Always prioritize open communication with your doctor regarding your breastfeeding journey.

Pediatric Use

It's important to be cautious when giving medication to children. For children under 12 years of age, this medication should not be used at all. If your child is 12 years or older, they can take 1 tablet every 4 hours, but make sure they do not exceed 6 doses in a 24-hour period. Always follow these guidelines to ensure their safety and well-being.

Geriatric Use

When it comes to using this medication in older adults, there is no specific information available about dosage adjustments, safety concerns, or special precautions. This means that if you or a loved one is an older adult, it’s important to consult with a healthcare provider before starting the medication. They can help determine the best approach based on individual health needs and any other medications being taken. Always prioritize open communication with your healthcare team to ensure safe and effective treatment.

Renal Impairment

If you have kidney problems, it's important to know that you may need a lower dose of this medication. Your doctor will determine the right dosage based on your creatinine clearance levels, which is a test that measures how well your kidneys are filtering waste from your blood.

To ensure your kidneys remain healthy while taking this medication, regular tests to check your renal function are recommended. If you have severe kidney impairment, your healthcare provider may need to monitor you more closely to adjust your treatment as necessary.

Hepatic Impairment

If you have liver problems, it's important to know that there are no specific guidelines or dosage adjustments mentioned for your condition in the available information. This means that the standard recommendations apply, but you should always consult your healthcare provider for personalized advice. They can help determine the best approach for your treatment and monitor your liver function as needed.

Make sure to keep your doctor informed about your liver health, as they may want to conduct regular liver function tests (which check how well your liver is working) to ensure your safety while using any medication.

Drug Interactions

It's important to be cautious when taking phenylephrine, especially if you are currently on a prescription monoamine oxidase inhibitor (MAOI) or have taken one in the past two weeks. Combining these medications can lead to a serious increase in blood pressure, known as severe hypertension.

Always discuss any medications you are taking with your healthcare provider to ensure your safety and avoid potentially harmful interactions. They can help you understand how different drugs may affect each other and your overall health.

Storage and Handling

To ensure the safety and effectiveness of your product, store it at room temperature, ideally between 59º-86º F (15º-30º C). It's important to keep the product in its tamper-evident sealed packets. If you notice any packets that are opened or torn, do not use them, as this could compromise the product's integrity.

By following these simple storage and handling guidelines, you can help maintain the quality and safety of the product for your use.

Additional Information

You should take this medication orally. For adults and children aged 12 years and older, the recommended dose is 1 tablet every 4 hours, but do not exceed 6 doses in a 24-hour period. It is important to note that this medication should not be given to children under 12 years of age. If you have any questions or concerns about taking this medication, be sure to consult with your healthcare provider.

FAQ

What is Physicians Care® Non-Drowsy Sinus Decongestant used for?

It temporarily relieves nasal congestion due to the common cold, hay fever, or other upper respiratory allergies, and also relieves sinus congestion and pressure.

What is the active ingredient in this medication?

The active ingredient is Phenylephrine HCl 10mg.

How should adults and children 12 years and older take this medication?

You should take 1 tablet every 4 hours, not exceeding 6 doses in 24 hours.

Can children under 12 years take this medication?

No, do not give this medication to children under 12 years of age.

What should I do if I experience nervousness, dizziness, or sleeplessness?

Stop using the medication and ask a doctor if you experience these symptoms.

Are there any contraindications for using this medication?

Do not use it if you are currently taking a prescription monoamine oxidase inhibitor (MAOI) or for 2 weeks after stopping an MAOI.

What should I do in case of an overdose?

Get emergency medical help or contact a Poison Control Center right away.

What precautions should I take if I have certain health conditions?

Ask a doctor before use if you have heart disease, high blood pressure, thyroid disease, diabetes, or trouble urinating due to an enlarged prostate gland.

Is it safe to use this medication during pregnancy or breastfeeding?

If pregnant or breastfeeding, ask a health professional before use.

How should I store this medication?

Store at room temperature between 59º-86º F (15º-30º C) and do not use any opened or torn packets.

Packaging Info

Below are the non-prescription pack sizes of Physicianscare Sinus (phenylephrine hcl). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Physicianscare Sinus.
Details

Drug Information (PDF)

This file contains official product information for Physicianscare Sinus, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the temporary relief of nasal congestion associated with the common cold, hay fever, or other upper respiratory allergies. It also provides temporary relief of sinus congestion and pressure, and promotes nasal and/or sinus drainage.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children aged 12 years and older are instructed to take 1 tablet every 4 hours as needed. The maximum allowable dosage is 6 tablets within a 24-hour period.

For children under 12 years of age, this medication is contraindicated and should not be administered.

Contraindications

Use of this product is contraindicated in patients currently taking a prescription monoamine oxidase inhibitor (MAOI) or within 2 weeks of discontinuing an MAOI. MAOIs are commonly prescribed for depression, psychiatric or emotional conditions, and Parkinson's disease. Patients should consult a healthcare professional if uncertain whether their prescription includes an MAOI.

Additionally, exceeding the recommended dosage is contraindicated, as it may lead to adverse effects.

Warnings and Precautions

Healthcare professionals should exercise caution when prescribing this medication. It is imperative to consult a physician prior to use in patients with a history of heart disease, high blood pressure, thyroid disease, diabetes, or urinary difficulties due to an enlarged prostate gland. These conditions may increase the risk of adverse effects or complications associated with the medication.

In the event of an overdose, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay. Prompt intervention is crucial to mitigate potential health risks.

Patients should be advised to discontinue use and consult their healthcare provider if they experience symptoms such as nervousness, dizziness, or insomnia. Additionally, if symptoms do not show improvement within seven days or are accompanied by fever, it is essential to seek medical advice to reassess the treatment plan.

Side Effects

Patients should be aware of the potential adverse reactions associated with the use of this product. While no specific side effects have been documented, it is important to monitor for certain symptoms. Patients are advised to stop use and consult a doctor if they experience nervousness, dizziness, or sleeplessness. Additionally, if symptoms do not improve within 7 days or are accompanied by fever, medical advice should be sought.

Before using this product, patients with pre-existing conditions should consult a healthcare professional. This includes individuals with heart disease, high blood pressure, thyroid disease, diabetes, or those experiencing difficulty urinating due to an enlarged prostate gland.

No further adverse reactions have been reported in clinical trials or postmarketing experiences.

Drug Interactions

The concomitant use of phenylephrine with prescription monoamine oxidase inhibitors (MAOIs) is contraindicated. Patients currently taking an MAOI or who have discontinued an MAOI within the past two weeks should avoid phenylephrine due to the risk of severe hypertension.

No additional drug interactions or laboratory test interactions have been identified. Therefore, no further dosage adjustments or monitoring recommendations are necessary beyond the contraindication noted above.

Packaging & NDC

Below are the non-prescription pack sizes of Physicianscare Sinus (phenylephrine hcl). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Physicianscare Sinus.
Details

Pediatric Use

Pediatric patients under 12 years of age should not be administered this medication. For adolescents aged 12 years and older, the recommended dosage is 1 tablet every 4 hours, with a maximum of 6 doses within a 24-hour period. Caution should be exercised to adhere to the specified dosing guidelines to ensure safety and efficacy in this age group.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully weighed, as the effects on fetal outcomes and lactation are not fully established. It is essential for women of childbearing potential to seek medical advice to ensure safe use during pregnancy and lactation.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is no specific data available regarding the excretion of this medication in breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment may require a reduced dose of the medication. Dosage adjustments should be based on creatinine clearance levels to ensure safety and efficacy. Regular renal function tests are recommended to monitor kidney health in patients receiving this medication. Additionally, special monitoring may be necessary for patients with severe renal impairment to address any potential risks associated with reduced kidney function.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant and prepared for potential scenarios involving overdose.

Healthcare providers should be aware that the clinical presentation of an overdose may vary depending on the substance involved and the individual patient’s characteristics. Symptoms of overdose can range from mild to severe and may include altered mental status, cardiovascular instability, respiratory distress, and gastrointestinal disturbances.

In the event of suspected overdosage, immediate medical evaluation is recommended. Healthcare professionals should assess the patient's vital signs and conduct a thorough clinical examination. Supportive care should be initiated as necessary, which may include airway management, intravenous fluids, and monitoring of vital parameters.

If specific antidotes or treatments are available for the substance involved, they should be administered according to established protocols. Consultation with a poison control center or toxicology expert may also be warranted to guide management decisions.

It is crucial to document all findings and interventions in the patient's medical record and to report any adverse events to the appropriate regulatory authorities as required.

Nonclinical Toxicology

If pregnant or breastfeeding, it is advised to consult a health professional prior to use. No specific non-teratogenic effects have been identified in the available data. Additionally, there are no detailed findings regarding nonclinical toxicology or animal pharmacology and toxicology provided in the current information.

Postmarketing Experience

No postmarketing experience details are available in the provided text.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of the reach of children to prevent accidental ingestion. In the event of an overdose, patients should be instructed to seek medical help or contact a Poison Control Center immediately.

Patients must be informed that this product should not be used concurrently with prescription monoamine oxidase inhibitors (MAOIs), which are medications prescribed for depression, psychiatric or emotional conditions, or Parkinson's disease. Additionally, patients should be cautioned against using this product for at least two weeks after discontinuing an MAOI. If patients are uncertain whether their prescription medication contains an MAOI, they should be encouraged to consult with their doctor or pharmacist prior to use.

Patients should be advised to discontinue use and consult a doctor if they experience symptoms such as nervousness, dizziness, or sleeplessness. Furthermore, if symptoms do not improve within seven days or are accompanied by fever, patients should seek medical advice.

It is essential to emphasize that patients should not exceed the recommended dosage while using this product. Healthcare providers should also recommend that patients consult a doctor before use if they have any of the following conditions: heart disease, high blood pressure, thyroid disease, diabetes, or difficulty urinating due to an enlarged prostate gland.

Storage and Handling

The product is supplied in tamper-evident sealed packets. It is essential to store the packets at room temperature, specifically within the range of 59º to 86º F (15º to 30º C). Healthcare professionals are advised to refrain from using any packets that are opened or torn, ensuring the integrity and safety of the product.

Additional Clinical Information

The medication is administered orally. For adults and children aged 12 years and older, the recommended dosage is one tablet every four hours, with a maximum of six doses within a 24-hour period. It is contraindicated for children under 12 years of age. No additional information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Physicianscare Sinus, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Physicianscare Sinus, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.